Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Logistics and Distribution to SNS/CHEMPACKs

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract encompasses the temperature-controlled logistics and distribution of finished autoinjectors to SNS and CHEMPACK sites, ensuring product integrity through strict thermal monitoring using TempTale devices throughout transit. All shipments must include comprehensive documentation of ambient exposure conditions to verify compliance with required temperature thresholds, with real-time and post-delivery data submission mandated to maintain accountability and regulatory adherence. The operation demands precision in handling, transport, and chain-of-custody procedures to safeguard the efficacy of medical countermeasures destined for federal emergency response stockpiles. Performance is centered at Washington DC with a 20024 ZIP code as the designated point of performance, and the contract falls under NAICS code 484220 for specialized truck transportation. It is structured as a subcontract under the Department of Health and Human Services via Barda-ASPR/DAAPPO, with responses due by July 30, 2026. The requirement emphasizes end-to-end control of environmental conditions, documentation rigor, and reliability in delivery to support national preparedness objectives, with no set-aside provisions indicated. All parties must adhere to federal standards for medical logistics without exception.

General Info

Temperature-controlled logistics for autoinjectors to federal stockpiles with real-time thermal monitoring and stringent documentation required.

Agency

Department Of Health And Human Services → Barda - Aspr / Daappo / Barda DcmaView Agency

NAICS

484220 - Specialized Freight (except Used Goods) Trucking, LocalView NAICS

Place of Performance

Washington, DC, 20024, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Barda - Aspr / Daappo / Barda Dcma
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → Barda - Aspr / Daappo / Barda Dcma
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Temperature-controlled delivery of finished autoinjectors to SNS and CHEMPACK sites with TempTale monitoring and ambient exposure documentation.

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Health And Human Services → Barda - Aspr / Daappo / Barda Dcma

Same awarding agency

NAICS: 541714
Federal
RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)The Biomedical Advanced Research and Development Authority (BARDA) is seeking proposals under solicitation 75A50126R00002 to develop, obtain regulatory approval for, and procure approximately two million 2-PAM (600mg) autoinjectors as a drug/device combination product for the treatment of organophosphate poisoning, including nerve agents, in both adult and pediatric populations. This effort supports the Strategic National Stockpile (SNS) and CHEMPACK Program. The contract is structured as a hybrid cost-plus-fixed-fee and firm-fixed-price instrument with an anticipated base performance period of up to 36 months and potential extension through options to a total duration of eight years. Key deliverables include late-stage clinical development, regulatory submission and approval, and large-scale manufacturing of autoinjectors, with production split across multiple CLINs totaling 2 million units. The solicitation is issued as a Statement of Objectives, requiring offerors to submit a comprehensive Statement of Work and Risk Mitigation Plan addressing program management, product development, supply chain logistics, and optional post-marketing commitments. Manufacturing and packaging must adhere to Good Manufacturing Practice regulations under 21 CFR Part 820, and all products must maintain strict temperature controls during transit, with ambient exposure logging required from the offeror’s validated facility until acceptance by the government at the ASPR/SNS location in Washington, D.C. All proposals must comply with mandatory eligibility criteria, including adherence to FAR and HHSAR clauses covering cost allowability, inspection, intellectual property, anti-kickback, and contingency fee restrictions. Offerors are required to complete SAM.gov representations and certifications, submit a detailed organizational chart identifying key personnel including a Program Director, Chief Scientific/Medical Officer, Manufacturing Lead, Regulatory Affairs Lead, and Project Manager, and demonstrate compliance with human subject protections under 45 CFR 46. Security requirements mandate layered physical controls, identification verification for personnel and visitors, and robust information and cyber security protocols encompassing access controls, intrusion detection, and encryption. Proposals must be submitted by July 30, 2026, and remain firm for 120 days. Evaluation will prioritize technical merit, past performance, and overall value over cost, with non-cost factors carrying significantly greater weight. Contract administration requires electronic invoice submissions via the Treasury IPP system to designated federal offices and strict adherence to documentation handling, packaging, and delivery protocols. The procurement is open to all qualified entities without set-aside restrictions
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

18 days ago

DEADLINE

in 4 days
View Details
NAICS: 325412
Federal
Consistency Lot and PPQ Manufacturing SupportThe contract titled Consistency Lot and PPQ Manufacturing Support is a subcontract aimed at producing consistency and process validation batches to ensure full compliance with current good manufacturing practices and to maintain regulatory readiness. The work is scheduled to support critical pharmaceutical manufacturing activities under the oversight of the Department of Health and Human Services through its agency Barda - Aspr / Daappo / Barda Dcma, with the primary place of performance located in Washington, DC, specifically at the zip code 20024. The North American Industry Classification System code 325412 indicates the scope involves pharmaceutical and botanical product manufacturing, underscoring the technical and regulatory rigor required for the deliverables. Interested parties must submit proposals by the response deadline of July 30, 2026, at 9:00 PM ET, following a solicitation posted on July 2, 2026. There is no set-aside designation specified, meaning the opportunity is open to all eligible contractors without preference based on business size or type. The contract is focused on delivering validated manufacturing outputs that meet strict quality benchmarks to support product approval and ongoing regulatory submissions, requiring the contractor to possess proven expertise in process validation, batch documentation, and adherence to cGMP standards throughout all phases of production.
Pharmaceutical Preparation Manufacturing

POSTED

24 days ago

DEADLINE

in 4 days
View Details